Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
Open Access
- 1 January 2008
- journal article
- review article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 14, 169-174
- https://doi.org/10.1111/j.1469-0691.2007.01856.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- CTX-M: changing the face of ESBLs in EuropeJournal of Antimicrobial Chemotherapy, 2006
- Efficacy of practised screening methods for detection of cephalosporin-resistant EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2006
- Resistance in Gram-Negative Bacteria: EnterobacteriaceaeAmerican Journal Of Medicine, 2006
- Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance ProgramDiagnostic Microbiology and Infectious Disease, 2006
- Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 β-lactams: adjustments of breakpoints for strains producing extended spectrum β-lactamasesDiagnostic Microbiology and Infectious Disease, 2005
- Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerationsClinical Microbiology & Infection, 2005
- Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -LactamasesClinical Infectious Diseases, 2004
- European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteriaJournal of Antimicrobial Chemotherapy, 2003
- Molecular Correlation for the Treatment Outcomes in Bloodstream Infections Caused byEscherichia coliandKlebsiella pneumoniaewith Reduced Susceptibility to CeftazidimeClinical Infectious Diseases, 2002
- Establishing MIC breakpoints and the interpretation of in vitro susceptibility testsJournal of Antimicrobial Chemotherapy, 2001